MaxCyte, Inc.
MaxCyte, Inc.（MXCT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mxct · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$6.00
+421.7% upside
Low
$6.00
Median: $6 · Last Close: $1.15
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.21 | ↑ 5.00% |
1-day model range: $1.19–$1.22. Peak: $1.22 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MXCT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-25 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-08-11 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2025-08-07 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2025-03-12 | Stifel | Maintains | Buy→Buy |
| 2024-04-23 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2024-03-13 | BTIG | Maintains | Buy→Buy |
| 2024-03-13 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2023-10-05 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2023-03-28 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2022-08-15 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on MaxCyte, Inc. (MXCT) stock. Of the recent 15 rating actions, 0 were upgrades and 2 were downgrades. 6 analysts currently cover MXCT.
分析师推荐趋势
MXCT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$35M
↓ 6.5% YoY
Revenue Next Year
$31M
↓ 11.5% YoY
EPS This Year
$-0.39
EPS Next Year
$-0.26
↓ 33.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MXCT EPS of $-0.39 for the current fiscal year, based on estimates from 3 analysts. The MXCT revenue forecast is $35M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MXCT 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MXCT 的共识目标价为 $6.00（+421.7% 上行空间），分析师共识为 Buy。
MXCT 的短期预测（明日）为 $1.21（+5.00%）。 MXCT 对 2027 年的股价预测均值为 $1。 MXCT 对 2030 年的预测区间为 $0–$0。
MaxCyte, Inc. 在 NASDAQ 上市，代码 MXCT。MXCT 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。
常见问题
MXCT 预测 · 8 个问题根据 6 位华尔街分析师，MXCT 的 12 个月平均目标价为 $6.00，最高 $6.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $1.15，隐含约 +421.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.